| prevalence of antibodies against simian immunodeficiency virus (siv) and simian t-lymphotropic virus (stlv) in a colony of non-human primates in kenya, east africa. | sera (165 samples in 1988 and 66, follow-up samples in 1989) were collected from olive baboons, african green monkeys, syke's monkeys and grey mangabeys kept in a semi-free, breeding colony at the institute of primate research (ipr) in nairobi, kenya. the levels of antibodies to simian t-lymphotropic virus (stlv) or simian immunodeficiency virus (siv), and the reactivity patterns of positive sera to various lentivirus subgroup antigens, were then determined. the results of tests using enzyme-imm ... | 1996 | 8729629 |
| development of a dna-mva/hiva vaccine for kenya. | without going into the details of the devastation that human immunodeficiency virus (hiv) infection causes especially in the developing world, the best hope for changing the course of this epidemic is development of a safe, effective, accessible prophylactic hiv vaccine. while the inaccessibility of potentially neutralising epitopes on primary hiv isolates has hampered the development of envelope-based vaccines, there is a number of new potent technologies capable of inducing high levels of circ ... | 2002 | 11983261 |